{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:02:30Z","timestamp":1767182550757,"version":"build-2238731810"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T00:00:00Z","timestamp":1449705600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144739","type":"journal-article","created":{"date-parts":[[2015,12,10]],"date-time":"2015-12-10T13:35:57Z","timestamp":1449754557000},"page":"e0144739","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"ntr3069","registry":"10.18810\/dutch-trial-register"}],"author":[{"given":"Alienke J.","family":"Wijmenga-Monsuur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"van Westen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riet M. C.","family":"Jongerius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Zancolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter G. M.","family":"van Gageldonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Tcherniaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy A. M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nynke Y.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,10]]},"reference":[{"issue":"12","key":"ref1","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.vaccine.2006.11.032","article-title":"Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998\u20132006)","volume":"25","author":"F Oosterhuis-Kafeja","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project","volume":"7","author":"HL Johnson","year":"2010","journal-title":"PLoS medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2334-13-70","article-title":"Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children","volume":"13","author":"M van der Linden","year":"2013","journal-title":"BMC infectious diseases"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","article-title":"Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis","volume":"7","author":"J Spijkerman","year":"2012","journal-title":"PloS one"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3201\/eid1704.101115","article-title":"Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands","volume":"17","author":"J Spijkerman","year":"2011","journal-title":"Emerging infectious diseases"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.3201\/eid1811.120329","article-title":"Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands","volume":"18","author":"AM van Deursen","year":"2012","journal-title":"Emerging infectious diseases"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","article-title":"Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands","volume":"16","author":"GD Rodenburg","year":"2010","journal-title":"Emerging infectious diseases"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","article-title":"The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review","volume":"30","author":"TT Myint","year":"2013","journal-title":"Advances in therapy"},{"key":"ref9","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine","author":"AATM Bosch","journal-title":"Emerging infectious diseases"},{"key":"ref10","article-title":"Incidence of invasive pneumococcal disease in the Netherlands in the first three years after introduction of 10-valent pneumococcal conjugate vaccination","author":"MJ Knol","journal-title":"Emergin Infectious Diseases"},{"key":"ref11","article-title":"Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England","author":"AJ van Hoek","year":"2014","journal-title":"Vaccine"},{"key":"ref12","article-title":"Evolving Role of 13-Valent Pneumococcal Conjugate Vaccine in Clinical Practice","author":"C Azzari","year":"2014","journal-title":"The Pediatric infectious disease journal"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1586\/erv.11.14","article-title":"Long-term protection after immunization with protein-polysaccharide conjugate vaccines in infancy","volume":"10","author":"G Blanchard-Rohner","year":"2011","journal-title":"Expert review of vaccines"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0105-2896.2006.00397.x","article-title":"Checkpoints in memory B-cell evolution","volume":"211","author":"LJ McHeyzer-Williams","year":"2006","journal-title":"Immunological reviews"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2567.2004.01971.x","article-title":"Haemophilus influenzae type b conjugate vaccines","volume":"113","author":"DF Kelly","year":"2004","journal-title":"Immunology"},{"issue":"4","key":"ref16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s281-001-8166-x","article-title":"Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations","volume":"23","author":"EE Adderson","year":"2001","journal-title":"Springer seminars in immunopathology"},{"issue":"14\u201315","key":"ref17","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0264-410X(98)00098-X","article-title":"Infant B cell responses to polysaccharide determinants","volume":"16","author":"GT Rijkers","year":"1998","journal-title":"Vaccine"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1100782108","article-title":"Oligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine","volume":"108","author":"J Kubler-Kielb","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CVI.00402-10","article-title":"Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines","volume":"18","author":"J Poolman","year":"2011","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1097\/INF.0b013e318199f8ef","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine","volume":"28","author":"T Vesikari","year":"2009","journal-title":"The Pediatric infectious disease journal"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1586\/erv.09.113","article-title":"10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix","volume":"8","author":"R Prymula","year":"2009","journal-title":"Expert review of vaccines"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes","volume":"8","author":"LR Grant","year":"2013","journal-title":"PloS one"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/cid\/cit428","article-title":"Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial","volume":"57","author":"R Dagan","year":"2013","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1097\/INF.0b013e31821a0614","article-title":"Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial","volume":"30","author":"MR van den Bergh","year":"2011","journal-title":"The Pediatric infectious disease journal"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/INF.0b013e3182323ac2","article-title":"Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants","volume":"31","author":"M Knuf","year":"2012","journal-title":"The Pediatric infectious disease journal"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40272-013-0047-z","article-title":"13-valent pneumococcal conjugate vaccine: a review of its use in infants, children, and adolescents","volume":"15","author":"GL Plosker","year":"2013","journal-title":"Paediatric drugs"},{"key":"ref27","article-title":"Differential B-Cell Memory Around the 11-Month Booster in Children Vaccinated With a 10- or 13-Valent Pneumococcal Conjugate Vaccine","author":"E van Westen","year":"2015","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00408-09","article-title":"Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine","volume":"17","author":"KE Elberse","year":"2010","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"9","key":"ref29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.2013.228052","article-title":"Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial","volume":"310","author":"J Spijkerman","year":"2013","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/CVI.00112-06","article-title":"Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies","volume":"13","author":"RL Burton","year":"2006","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"1\u20132","key":"ref31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"PG van Gageldonk","year":"2008","journal-title":"Journal of immunological methods"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CVI.00364-08","article-title":"Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay","volume":"16","author":"RM de Voer","year":"2009","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/CVI.05081-11","article-title":"Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid","volume":"18","author":"PG van Gageldonk","year":"2011","journal-title":"Clinical and vaccine immunology: CVI"},{"issue":"4","key":"ref34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers","volume":"25","author":"D Goldblatt","year":"2006","journal-title":"The Pediatric infectious disease journal"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1542\/peds.2010-1184","article-title":"Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine","volume":"128","author":"F Omenaca","year":"2011","journal-title":"Pediatrics"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1097\/INF.0b013e3181b48ca3","article-title":"Immunogenicity of a 2-dose priming and booster vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine","volume":"28","author":"SA Silfverdal","year":"2009","journal-title":"The Pediatric infectious disease journal"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/INF.0b013e3181dffabf","article-title":"Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months","volume":"29","author":"T Vesikari","year":"2010","journal-title":"The Pediatric infectious disease journal"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/INF.0b013e318199f609","article-title":"Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different Neisseria meningitidis serogroup C conjugate vaccines","volume":"28","author":"J Wysocki","year":"2009","journal-title":"The Pediatric infectious disease journal"},{"key":"ref39","unstructured":"Bergh van den MR. Nasopharyngeal colonization with respiratory pathogens. Thesis. 2013."},{"issue":"19","key":"ref40","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2007.01.119","article-title":"Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies","volume":"25","author":"GR Siber","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study","volume":"14","author":"NJ Andrews","year":"2014","journal-title":"The Lancet Infectious diseases"},{"issue":"12","key":"ref42","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1086\/593339","article-title":"Differential effects of pneumococcal vaccines against serotypes 6A and 6C","volume":"198","author":"IH Park","year":"2008","journal-title":"The Journal of infectious diseases"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1128\/CVI.00248-12","article-title":"Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine","volume":"19","author":"B Simell","year":"2012","journal-title":"Clinical and vaccine immunology: CVI"},{"key":"ref44","unstructured":"van 't Schurink-van \u2018t Klooster TM, de Melker HE, van der Avoort HGAM, van Beers CJAM, Benschop K, G.A.M. Berbers, et al. The National Immunisation Programme; Surveillance and developments in 2013\u20132014 in the Netherlands. RIVM Report 151103001\/2014. 2014."},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-2600(14)70060-8","article-title":"Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study","volume":"2","author":"CM Domingues","year":"2014","journal-title":"The Lancet Respiratory medicine"},{"issue":"9862","key":"ref46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial","volume":"381","author":"AA Palmu","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1542\/peds.2009-3027","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers","volume":"126","author":"SH Yeh","year":"2010","journal-title":"Pediatrics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2431-10-4","article-title":"Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?","volume":"10","author":"WP Hausdorff","year":"2010","journal-title":"BMC pediatrics"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/657070","article-title":"Pre- and post-conjugate vaccine epidemiology of pneumococcal serotype 6C invasive disease and carriage within Navajo and White Mountain Apache communities","volume":"51","author":"EV Millar","year":"2010","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"9546","key":"ref50","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study","volume":"368","author":"CG Whitney","year":"2006","journal-title":"Lancet"},{"issue":"8","key":"ref51","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"ZB Harboe","year":"2014","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"3","key":"ref52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/INF.0b013e318275614b","article-title":"Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine","volume":"32","author":"SL Kaplan","year":"2013","journal-title":"The Pediatric infectious disease journal"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1139\/cjm-2013-0614","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010\u20132012","volume":"59","author":"WH Demczuk","year":"2013","journal-title":"Canadian journal of microbiology"},{"issue":"4","key":"ref54","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1097\/INF.0b013e318199f61b","article-title":"Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)","volume":"28","author":"M Knuf","year":"2009","journal-title":"The Pediatric infectious disease journal"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0155088","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T04:23:00Z","timestamp":1540268580000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144739"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,10]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144739","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,10]]}}}